TREAT Asia Awarded Five-Year NIH Research Grant
Dr. Nittaya PhanuphakTREAT Asia has been awarded a new grant from the U.S. National Institutes of Health to study human papillomavirus, the cause of cervical and anal cancer, in perinatally HIV-infected female and male adolescents with HIV in Thailand and Vietnam. The grant builds on earlier research conducted with the Thai Red Cross AIDS Research Centre. This innovative study reflects TREAT Asia's growing commitment to better understanding the long-term impact of HIV on adolescents growing up with the infection.
TREAT Asia Director Dr. Annette Sohn and Dr. Nittaya Phanuphak from the Thai Red Cross AIDS Research Centre are Co-Principal Investigators on the project.
“Increasing prevalence and incidence of HPV-related pre-cancers and cancers of the cervix and anus have been seen among adults with HIV infection, even in the era of highly active antiretroviral therapy (HAART),” says Dr. Phanuphak. “This grant will allow us to study how prolonged immune suppression experienced by our adolescents infected with HIV perinatally may have additional effects on these HPV-related diseases. The results will help inform screening and prevention policies on HPV-related diseases among perinatally infected adolescents."
A Deadly Nexus: Cancer and HIV in Asia
Thai MSM Clinic Conducts Innovative Studies of Anal Cancer and HIV
Improving Understanding of Anal Cancer Risk Among MSM in Thailand
Investing in Research to Improve Adolescent HIV Care
HPV Infection and Cervical Cancer in HIV-Positive Women